Implementation of a Clinical Decision Support (CDS) Tool for the Management of Functional Constipation in Pediatric

Jennifer B Webster1,2, Eli M Lourie2,3, L Gregory Lawton3

  • 1Department of Pediatrics, Division of Gastroenterology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Clinical Pediatrics
|June 8, 2022
PubMed

Insights

A new clinical decision tool helps primary care providers manage pediatric constipation, improving workflow and reducing unnecessary referrals to pediatric gastroenterology specialists. This pilot initiative shows feasibility for enhanced primary care of children with constipation.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Informatics
  • Quality Improvement Science

Background:

  • Pediatric constipation is a frequent issue in general pediatrics, often leading to referrals to subspecialists.
  • Current management pathways may result in unnecessary subspecialty care, impacting healthcare resources and patient access.
  • Challenges in primary care management necessitate innovative solutions to optimize pediatric constipation care.

Purpose of the Study:

  • To develop and implement a clinical decision support tool for managing pediatric constipation in primary care.
  • To evaluate the impact of this tool on provider workflow, confidence, and subspecialty referral rates.
  • To assess the feasibility of integrating decision support into electronic health records for pediatric constipation management.

Main Methods:

  • A multidisciplinary team conducted a root cause analysis of challenges in pediatric constipation care.
  • A Clinical Decision Support tool and patient educational materials were developed.
  • These interventions were embedded within an electronic health record order-set and implemented in a primary care network.

Main Results:

  • The use of the updated electronic health record order-set has shown a consistent monthly increase.
  • Primary care providers reported improvements in workflow and increased confidence in managing pediatric constipation.
  • The interventions demonstrated feasibility for supporting primary care clinicians.

Conclusions:

  • Implementing a Clinical Decision Support tool is a feasible strategy to enhance primary care management of pediatric constipation.
  • Such tools can potentially reduce unnecessary referrals to pediatric gastroenterology.
  • This quality improvement initiative highlights the value of integrated electronic health record tools in pediatric primary care.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
353
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
323
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
545
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
257
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
317
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
226